MARKET

LENZ

LENZ

LENZ THERAPEUTICS INC
NASDAQ
5.82
+0.31
+5.63%
After Hours: 5.85 +0.03 +0.52% 19:50 06/26 EDT
OPEN
5.46
PREV CLOSE
5.51
HIGH
5.84
LOW
5.45
VOLUME
1.86M
TURNOVER
--
52 WEEK HIGH
50.40
52 WEEK LOW
5.23
MARKET CAP
182.48M
P/E (TTM)
-1.6194
1D
5D
1M
3M
1Y
5Y
1D
ANALYSIS-US prices for new drugs fell in 2025 as fewer costly gene therapies were launched
Reuters · 4d ago
LENZ Therapeutics And Arrotex Partner To Commercialize VIZZ In Australia And New Zealand
NASDAQ · 4d ago
LENZ Therapeutics Eye Drug Profile Supports Blockbuster Opportunity: Analyst
Benzinga · 4d ago
LENZ Therapeutics And Arrotex Pharma Announce Exclusive License And Commercialization Agreement For Arrotex To Register And Commercialize VIZZ For Treatment Of Presbyopia In Australia And New Zealand
Benzinga · 4d ago
LENZ THERAPEUTICS - ARROTEX OBTAINS EXCLUSIVE COMMERCIALIZATION RIGHTS FOR VIZZ IN AUSTRALIA AND NEW ZEALAND
Reuters · 5d ago
Weekly Report: what happened at LENZ last week (0615-0619)?
Weekly Report · 06/22 10:23
Weekly Report: what happened at LENZ last week (0608-0612)?
Weekly Report · 06/15 10:24
LENZ Therapeutics Shareholders Back Board and Auditor Slate
TipRanks · 06/12 20:49
More
About LENZ
LENZ Therapeutics, Inc. is a pre-commercial stage biopharmaceutical company. The Company is focused on the development and commercialization of aceclidine-based eye drop to improve near vision in patients with presbyopia. The Company’s lead product candidate LNZ100 is a preservative-free, single-use, once-daily eye drop containing aceclidine. LNZ100 was evaluated in the registration-enabling Phase III CLARITY study as a potential therapy for the treatment of presbyopia, a condition impacting over 1.8 billion people globally and 128 million people in the United States. Its other product LNZ101, is a preservative-free eye drop containing aceclidine and brimonidine.

Webull offers Lenz Therapeutics Inc stock information, including NASDAQ: LENZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LENZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LENZ stock methods without spending real money on the virtual paper trading platform.